Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > What?

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Apr 27, 2023 9:56am

131 Views

Post# 35416760

RE:RE:RE:RE:RE:RE:What?

I would agree Rump, and also dosage may also be able to be upped in future studies if needed, due to its safety profile, lets keep the good numbers coming and get BTD sooner than later so we can all have peace of mind. Also , good dicussion is always warranted, one opinion DOES not make right

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3